Abstract:Background and Aims Others and we have previously demonstrated that cAMP/PKA signalling stabilise endothelial cell (EC) barrier function via modulating the activities of Rho GTPases, mainly RhoA and Rac1. In the present study we analysed whether cAMP/PKA also modulates EC angiogenesis capacity and whether Rho GTPases are involved in this function. Methods The study was carried out on cultured human umbilical vein ECs (HUVECs). RhoA and Rac1 activities were genetically manipulated by lentiviral-mediated over expression of dominant negative (DN) and constitutive active (CA) forms of RhoA and Rac1. Pharmacologically, specific activation and inhibition of PKA was achieved by using cAMP analogue N6-Benzoyl-cAMP (5 mM) and PKI (1 μM), respectively. Pharmacologically, Rac1 was inhibited using NSC 23766 (10 μM) and RhoA was activated using Rho activator I (Cytoskeleton Inc.). In vitro angiogenesis was analysed by 3-D spheroid assay and matrigel tube formation assay. Results Pharmacologically, specific activation of PKA induced EC migration (Wound healing assay), tube formation, and 3-D spheroids and potentiated the VEGF-induced in vitro angiogenesis. These pro-angiogenesis activities were abrogated by highly specific cell-permeable peptide inhibitor (PKI) of PKA. Activation of cAMP/PKA-signalling resulted in an increased VEGFR2 and Akt phosphorylation, increased Rac1 activity, and a strong inhibition of RhoA/Rock pathway. Pharmacological activation of RhoA but not inhibition of Rac1 abrogated PKA-induced VEGFR2 phosphorylation, tube formation and 3-D spheroids. Lentiviral mediated over-expression of constitutive active form of RhoA but not Rac1 abrogated PKA-induced VEGFR2 and Akt phosphorylation and angiogenesis. Moreover, pharmacological inhibition of Akt also abrogated PKA-mediated VEGFR2 phosphorylation and angiogenesis. Likewise, over expression of either dominant negative RhoA or pharmacological inhibitors of Rho kinase (ROCK) promoted basal and potentiated PKA-mediated VEGFR2 and Akt phosphorylation and angiogenesis. Conclusion We describe for the first time a novel interplay between PKA, RhoA/ROCK, Akt, and VEGFR2 signalling and angiogenesis. Inhibition of RhoA/ROCK plays an important role in mediating PKA-induced angiogenesis and activation of RhoA/ROCK signalling may offer an important target to intervene therapeutic angiogenesis.

Dual Roles of Protein Tyrosine Phosphatase Kappa in Coordinating Angiogenesis Induced by Pro-Angiogenic Factors

The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis

Protein Tyrosine Phosphatase Kappa (PTPRK) is a Negative Regulator of Adhesion and Invasion of Breast Cancer Cells, and Associates with Poor Prognosis of Breast Cancer

The receptor protein tyrosine phosphatase PTPRK promotes intestinal repair and catalysis-independent tumour suppression

Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2*

PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway

Proteomics Identifies Thymidine Phosphorylase As A Key Regulator Of The Angiogenic Potential Of Colony Forming Units And Endothelial Progenitor Cell Cultures

RKTG Inhibits Angiogenesis by Suppressing MAPK-mediated Autocrine VEGF Signaling and is Downregulated in Clear-Cell Renal Cell Carcinoma

Dual Roles of the AMP-Activated Protein Kinase Pathway in Angiogenesis

Compensatory Role for Proline-Rich Tyrosine Kinase 2 (pyk2) During Angiogenesis in Adult Mice Lacking Endothelial Cell Focal Adhesion Kinase (FAK)

C-Jun N-Terminal Kinase Mediated VEGFR2 Sustained Phosphorylation is Critical for VEGFA-Induced Angiogenesis in Vitro and in Vivo

Receptor-like Protein Tyrosine Phosphatase Κ Negatively Regulates the Apoptosis of Prostate Cancer Cells Via the JNK Pathway.

Antagonistic Effects of Protein Kinase C Α and Δ on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor

cAMP/PKA-mediated in vitro angiogenesis: A novel interplay between PKA, RhoA/ROCK, and VEGFR2 signalling

Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-Kappa (ptp) and Protein Tyrosine Phosphatase-Mu (ptp Mu)

Involvement of C-Jun N-terminal Kinase and Extracellular Signal-Regulated Kinase 1/2 in EGF-induced Angiogenesis.

Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis—New insight and futuristic vision

Protein Phosphotyrosine Phosphatase 1b (ptp1b) in Calpain-Dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (vegfr2) in Endothelial Cells Implications in Vegf-Dependent Angiogenesis and Diabetic Wound Healing

[The Regulating Roles of Angiopoietins/tek-2 in Angiogenesis].

Supplementary Data from Down-Regulation of 3-Phosphoinositide–dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells